Table 1.
Number | 24 |
Male:Female | 15:9 |
Age in Yrs at Baseline, mean/SD/range | 66.1/7.22/52–77 |
Patients on Cholinesterase Inhibitors/Memantine | Baseline: 6/0 Follow-Up: 18/2 |
Number | 24 |
Male:Female | 15:9 |
Age in Yrs at Baseline, mean/SD/range | 66.1/7.22/52–77 |
Patients on Cholinesterase Inhibitors/Memantine | Baseline: 6/0 Follow-Up: 18/2 |